Selected research
Market Structure
Global Cannabigerol Gummies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cannabigerol Gummies market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Cannabigerol Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cannabigerol Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cannabigerol Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cannabigerol Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cannabigerol Gummies include Lazarus Naturals, Medterra CBD, Endoca, Extract Labs, NuLeaf Naturals, Neurogan, Proleve Distribution, Isodiol and CBDistillery, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Cannabigerol Gummies market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cannabigerol Gummies and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cannabigerol Gummies sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cannabigerol Gummies market size, projected growth trends, production technologies, key applications, and end-use industries.
Cannabigerol Gummies Segment by Company
Lazarus Naturals
Medterra CBD
Endoca
Extract Labs
NuLeaf Naturals
Neurogan
Proleve Distribution
Isodiol
CBDistillery
Elixinol Wellness
Joy Organics
CBD American Shaman
Steves Goods
CannaCare Health
Fab CBD
Vesl Oils
Cannabigerol Gummies Segment by Type
Full Spectrum CBG Gummies
Broad Spectrum CBG Gummies
Cannabigerol Gummies Segment by Application
Pain Relief
Anti-inflammatory
Reduce Anxiety
Other
Cannabigerol Gummies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cannabigerol Gummies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cannabigerol Gummies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cannabigerol Gummies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cannabigerol Gummies market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cannabigerol Gummies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cannabigerol Gummies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cannabigerol Gummies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Full Spectrum CBG Gummies
- Broad Spectrum CBG Gummies
Applications
- Pain Relief
- Anti-inflammatory
- Reduce Anxiety
- Other
Companies covered
- Lazarus Naturals
- Medterra CBD
- Endoca
- Extract Labs
- NuLeaf Naturals
- Neurogan
- Proleve Distribution
- Isodiol
- CBDistillery
- Elixinol Wellness
- Joy Organics
- CBD American Shaman
- Steves Goods
- CannaCare Health
- Fab CBD
- Vesl Oils
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cannabigerol Gummies Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cannabigerol Gummies Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cannabigerol Gummies Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cannabigerol Gummies Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cannabigerol Gummies Market Dynamics
- 2.1 Cannabigerol Gummies Industry Trends
- 2.2 Cannabigerol Gummies Industry Drivers
- 2.3 Cannabigerol Gummies Industry Opportunities and Challenges
- 2.4 Cannabigerol Gummies Industry Restraints
3 Cannabigerol Gummies Market by Manufacturers
- 3.1 Global Cannabigerol Gummies Revenue by Manufacturers (2021-2026)
- 3.2 Global Cannabigerol Gummies Sales by Manufacturers (2021-2026)
- 3.3 Global Cannabigerol Gummies Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cannabigerol Gummies Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cannabigerol Gummies Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cannabigerol Gummies Manufacturers, Product Type & Application
- 3.7 Global Cannabigerol Gummies Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cannabigerol Gummies Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cannabigerol Gummies Players Market Share by Revenue in 2025
- 3.8.3 2025 Cannabigerol Gummies Tier 1, Tier 2, and Tier 3
4 Cannabigerol Gummies Market by Type
- 4.1 Cannabigerol Gummies Type Introduction
- 4.1.1 Full Spectrum CBG Gummies
- 4.1.2 Broad Spectrum CBG Gummies
- 4.2 Global Cannabigerol Gummies Sales by Type
- 4.2.1 Global Cannabigerol Gummies Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cannabigerol Gummies Sales by Type (2021-2032)
- 4.2.3 Global Cannabigerol Gummies Sales Market Share by Type (2021-2032)
- 4.3 Global Cannabigerol Gummies Revenue by Type
- 4.3.1 Global Cannabigerol Gummies Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cannabigerol Gummies Revenue by Type (2021-2032)
- 4.3.3 Global Cannabigerol Gummies Revenue Market Share by Type (2021-2032)
5 Cannabigerol Gummies Market by Application
- 5.1 Cannabigerol Gummies Application Introduction
- 5.1.1 Pain Relief
- 5.1.2 Anti-inflammatory
- 5.1.3 Reduce Anxiety
- 5.1.4 Other
- 5.2 Global Cannabigerol Gummies Sales by Application
- 5.2.1 Global Cannabigerol Gummies Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cannabigerol Gummies Sales by Application (2021-2032)
- 5.2.3 Global Cannabigerol Gummies Sales Market Share by Application (2021-2032)
- 5.3 Global Cannabigerol Gummies Revenue by Application
- 5.3.1 Global Cannabigerol Gummies Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cannabigerol Gummies Revenue by Application (2021-2032)
- 5.3.3 Global Cannabigerol Gummies Revenue Market Share by Application (2021-2032)
6 Global Cannabigerol Gummies Sales by Region
- 6.1 Global Cannabigerol Gummies Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cannabigerol Gummies Sales by Region (2021-2032)
- 6.2.1 Global Cannabigerol Gummies Sales by Region (2021-2026)
- 6.2.2 Global Cannabigerol Gummies Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cannabigerol Gummies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cannabigerol Gummies Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cannabigerol Gummies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cannabigerol Gummies Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cannabigerol Gummies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cannabigerol Gummies Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cannabigerol Gummies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cannabigerol Gummies Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cannabigerol Gummies Revenue by Region
- 7.1 Global Cannabigerol Gummies Revenue by Region
- 7.1.1 Global Cannabigerol Gummies Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cannabigerol Gummies Revenue by Region (2021-2026)
- 7.1.3 Global Cannabigerol Gummies Revenue by Region (2027-2032)
- 7.1.4 Global Cannabigerol Gummies Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cannabigerol Gummies Revenue (2021-2032)
- 7.2.2 North America Cannabigerol Gummies Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cannabigerol Gummies Revenue (2021-2032)
- 7.3.2 Europe Cannabigerol Gummies Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cannabigerol Gummies Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cannabigerol Gummies Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cannabigerol Gummies Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cannabigerol Gummies Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Lazarus Naturals
- 8.1.1 Lazarus Naturals Company Information
- 8.1.2 Lazarus Naturals Business Overview
- 8.1.3 Lazarus Naturals Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Lazarus Naturals Cannabigerol Gummies Product Portfolio
- 8.1.5 Lazarus Naturals Recent Developments
- 8.2 Medterra CBD
- 8.2.1 Medterra CBD Company Information
- 8.2.2 Medterra CBD Business Overview
- 8.2.3 Medterra CBD Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Medterra CBD Cannabigerol Gummies Product Portfolio
- 8.2.5 Medterra CBD Recent Developments
- 8.3 Endoca
- 8.3.1 Endoca Company Information
- 8.3.2 Endoca Business Overview
- 8.3.3 Endoca Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Endoca Cannabigerol Gummies Product Portfolio
- 8.3.5 Endoca Recent Developments
- 8.4 Extract Labs
- 8.4.1 Extract Labs Company Information
- 8.4.2 Extract Labs Business Overview
- 8.4.3 Extract Labs Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Extract Labs Cannabigerol Gummies Product Portfolio
- 8.4.5 Extract Labs Recent Developments
- 8.5 NuLeaf Naturals
- 8.5.1 NuLeaf Naturals Company Information
- 8.5.2 NuLeaf Naturals Business Overview
- 8.5.3 NuLeaf Naturals Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 NuLeaf Naturals Cannabigerol Gummies Product Portfolio
- 8.5.5 NuLeaf Naturals Recent Developments
- 8.6 Neurogan
- 8.6.1 Neurogan Company Information
- 8.6.2 Neurogan Business Overview
- 8.6.3 Neurogan Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Neurogan Cannabigerol Gummies Product Portfolio
- 8.6.5 Neurogan Recent Developments
- 8.7 Proleve Distribution
- 8.7.1 Proleve Distribution Company Information
- 8.7.2 Proleve Distribution Business Overview
- 8.7.3 Proleve Distribution Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Proleve Distribution Cannabigerol Gummies Product Portfolio
- 8.7.5 Proleve Distribution Recent Developments
- 8.8 Isodiol
- 8.8.1 Isodiol Company Information
- 8.8.2 Isodiol Business Overview
- 8.8.3 Isodiol Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Isodiol Cannabigerol Gummies Product Portfolio
- 8.8.5 Isodiol Recent Developments
- 8.9 CBDistillery
- 8.9.1 CBDistillery Company Information
- 8.9.2 CBDistillery Business Overview
- 8.9.3 CBDistillery Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 CBDistillery Cannabigerol Gummies Product Portfolio
- 8.9.5 CBDistillery Recent Developments
- 8.10 Elixinol Wellness
- 8.10.1 Elixinol Wellness Company Information
- 8.10.2 Elixinol Wellness Business Overview
- 8.10.3 Elixinol Wellness Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Elixinol Wellness Cannabigerol Gummies Product Portfolio
- 8.10.5 Elixinol Wellness Recent Developments
- 8.11 Joy Organics
- 8.11.1 Joy Organics Company Information
- 8.11.2 Joy Organics Business Overview
- 8.11.3 Joy Organics Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Joy Organics Cannabigerol Gummies Product Portfolio
- 8.11.5 Joy Organics Recent Developments
- 8.12 CBD American Shaman
- 8.12.1 CBD American Shaman Company Information
- 8.12.2 CBD American Shaman Business Overview
- 8.12.3 CBD American Shaman Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 CBD American Shaman Cannabigerol Gummies Product Portfolio
- 8.12.5 CBD American Shaman Recent Developments
- 8.13 Steves Goods
- 8.13.1 Steves Goods Company Information
- 8.13.2 Steves Goods Business Overview
- 8.13.3 Steves Goods Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Steves Goods Cannabigerol Gummies Product Portfolio
- 8.13.5 Steves Goods Recent Developments
- 8.14 CannaCare Health
- 8.14.1 CannaCare Health Company Information
- 8.14.2 CannaCare Health Business Overview
- 8.14.3 CannaCare Health Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 CannaCare Health Cannabigerol Gummies Product Portfolio
- 8.14.5 CannaCare Health Recent Developments
- 8.15 Fab CBD
- 8.15.1 Fab CBD Company Information
- 8.15.2 Fab CBD Business Overview
- 8.15.3 Fab CBD Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Fab CBD Cannabigerol Gummies Product Portfolio
- 8.15.5 Fab CBD Recent Developments
- 8.16 Vesl Oils
- 8.16.1 Vesl Oils Company Information
- 8.16.2 Vesl Oils Business Overview
- 8.16.3 Vesl Oils Cannabigerol Gummies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Vesl Oils Cannabigerol Gummies Product Portfolio
- 8.16.5 Vesl Oils Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cannabigerol Gummies Value Chain Analysis
- 9.1.1 Cannabigerol Gummies Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cannabigerol Gummies Production Mode & Process
- 9.2 Cannabigerol Gummies Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cannabigerol Gummies Distributors
- 9.2.3 Cannabigerol Gummies Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst